Sebenzile K. Myeni

ORCID: 0000-0002-5813-0065
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • Long-Term Effects of COVID-19
  • Escherichia coli research studies
  • Viral gastroenteritis research and epidemiology
  • Salmonella and Campylobacter epidemiology
  • Immunotherapy and Immune Responses
  • vaccines and immunoinformatics approaches
  • SARS-CoV-2 detection and testing
  • interferon and immune responses
  • Brucella: diagnosis, epidemiology, treatment
  • Virus-based gene therapy research
  • Vibrio bacteria research studies
  • Bacteriophages and microbial interactions
  • Burkholderia infections and melioidosis
  • Mechanical Circulatory Support Devices
  • Phagocytosis and Immune Regulation
  • Transgenic Plants and Applications
  • Viral Infectious Diseases and Gene Expression in Insects
  • COVID-19 Impact on Reproduction
  • Transplantation: Methods and Outcomes
  • Monoclonal and Polyclonal Antibodies Research
  • Vaccine Coverage and Hesitancy
  • Virology and Viral Diseases

Leiden University Medical Center
2020-2025

National Institutes of Health
2013-2023

National Institute of Allergy and Infectious Diseases
2013-2023

Leiden University
2021

Loyola University Medical Center
2021

Purdue University West Lafayette
2010-2013

Development of effective preventative interventions against SARS-CoV-2, the etiologic agent COVID-19 is urgently needed. The viral surface spike (S) protein SARS-CoV-2 a key target for prophylactic measures as it critical replication cycle and primary neutralizing antibodies. We evaluated design elements previously shown other coronavirus S protein-based vaccines to be successful, e.g., prefusion-stabilizing substitutions heterologous signal peptides, selection S-based vaccine candidate. In...

10.1038/s41541-020-00243-x article EN cc-by npj Vaccines 2020-09-28
Anna H.E. Roukens Cilia R. Pothast Marion König Wesley Huisman Tim J. Dalebout and 92 more Tamar Tak Shohreh Azimi Yvonne C. M. Kruize Renate S. Hagedoorn Mihaela Zlei Frank J. T. Staal Fenna De Bie Jacques J. M. van Dongen M. Sesmu Arbous Jaimie L. H. Zhang Maaike Verheij Corine Prins Anne M. van der Does Pieter S. Hiemstra Jutte J.C. de Vries Jacqueline J. Janse Meta Roestenberg Sebenzile K. Myeni Marjolein Kikkert Maria Yazdanbakhsh Mirjam H.M. Heemskerk Hermelijn H. Smits Simon P. Jochems M. Sesmu Arbous Bernard M. van den Berg Sandra de Bruin-Versteeg Suzanne C. Cannegieter K. Canté Christa M. Cobbaert Anne M. van der Does Jacques J. M. van Dongen Jeroen Eikenboom Mariet C.W. Feltkamp Annemieke Geluk Jelle J. Goeman Martin Giera Rick J. Groenland Thomas Hankemeier Mirjam H.M. Heemskerk Pieter S. Hiemstra Cornelis H. Hokke Rosalie van der Holst Jacqueline J. Janse Simon P. Jochems Simone A. Joosten Marjolein Kikkert S. Klaver Flores Lieke Lamont Judith Manniën Bas de Mooij Tom H. M. Ottenhoff Karin Pike‐Overzet Tamás Pongrácz Michaela Prado N. Queralt Rosinach Meta Roestenberg Marco Roos Anna H.E. Roukens Alita J. van der Sluijs‐Gelling Hermelijn H. Smits Eric J. Snijder Frank J. T. Staal Leendert A. Trouw Roula Tsonaka Aswin Verhoeven Leo G. Visser Jutte J.C. de Vries David J. van Westerloo Jeanette Wigbers H.J. van Wijk Robin C. van Wissen Manfred Wuhrer Maria Yazdanbakhsh Mihaela Zlei Josine A. Oud Meryem Baysan Jeanette Wigbers Lieke J. van Heurn Susan B. ter Haar Alexandra G. L. Toppenberg Laura Heerdink Annekee A. van IJlzinga Veenstra Anna M. Eikenboom Julia M. Wubbolts Jonathan W. Uzorka Willem M. Lijfering Romy Meier I. De Jonge Mark de Boer Anske G. van der Bom Olaf M. Dekkers Frits R. Rosendaal

10.1038/s41590-021-01095-w article EN Nature Immunology 2021-12-22

Abstract The rapid development of a SARS-CoV-2 vaccine is global priority. Here, we develop two capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) spike protein. RBD antigens are displayed on AP205 CLPs through split-protein Tag/Catcher, ensuring unidirectional and high-density display RBD. Both soluble recombinant bind ACE2 receptor with nanomolar affinity. Mice vaccinated or CLP-displayed RBD, formulated in Squalene-Water-Emulsion. RBD-CLP induce higher...

10.1038/s41467-020-20251-8 article EN cc-by Nature Communications 2021-01-12

The intracellular pathogenic bacterium Brucella generates a replicative vacuole (rBCV) derived from the endoplasmic reticulum via subversion of host cell secretory pathway. rBCV biogenesis requires expression Type IV secretion system (T4SS) VirB, which is thought to translocate effector proteins that modulate membrane trafficking along endocytic and pathways. To date, only few T4SS substrates have been identified, whose molecular functions remain unknown. Here, we used an in silico screen...

10.1371/journal.ppat.1003556 article EN cc-by PLoS Pathogens 2013-08-08

Safe and effective coronavirus disease–19 (COVID-19) vaccines are urgently needed to control the ongoing pandemic. While single-dose vaccine regimens would provide multiple advantages, two doses may improve magnitude durability of immunity protective efficacy. We assessed one- two-dose Ad26.COV2.S candidate in adult aged nonhuman primates (NHPs). A regimen induced higher peak binding neutralizing antibody responses compared with a single dose. In one-dose regimens, were stable for at least...

10.1084/jem.20202756 article EN cc-by-nc-sa The Journal of Experimental Medicine 2021-04-28

Understanding the mechanisms and impact of booster vaccinations are essential in design delivery vaccination programs. Here we show that a three dose regimen synthetic peptide vaccine elicits an accruing CD8+ T cell response against one SARS-CoV-2 Spike epitope. We see protection lethal infection K18-hACE2 transgenic mouse model absence neutralizing antibodies, but two approaches insufficient to confer protection. The third single epitope results superior generation effector-memory cells...

10.1038/s41467-022-31721-6 article EN cc-by Nature Communications 2022-07-08

The coronavirus papain-like protease (PLpro) is crucial for viral replicase polyprotein processing. Additionally, PLpro can subvert host defense mechanisms by its deubiquitinating (DUB) and deISGylating activities. To elucidate the role of these activities during SARS-CoV-2 infection, we introduced mutations that disrupt binding to ubiquitin or ISG15. We identified several strongly reduced DUB activity PLpro, without affecting In contrast, abrogated also hampered processing when into virus...

10.1371/journal.ppat.1012100 article EN cc-by PLoS Pathogens 2024-03-25

Previously we have shown that a single dose of recombinant adenovirus serotype 26 (Ad26) vaccine expressing prefusion stabilized SARS-CoV-2 spike antigen (Ad26.COV2.S) is immunogenic and provides protection in Syrian hamster non-human primate infection models. Here, investigated the immunogenicity, protective efficacy, potential for vaccine-associated enhanced respiratory disease (VAERD) mediated by Ad26.COV2.S moderate challenge model, using currently most prevalent G614 variant. Vaccine...

10.1038/s41541-021-00301-y article EN cc-by npj Vaccines 2021-03-19

Salmonella enterica serovar Typhimurium invade non-phagocytic cells by injecting bacterial effector proteins to exploit the host actin cytoskeleton network. SipC is such a known nucleate actin, bundle F-actin, and translocate type III effectors. The molecular mechanism of how bundles F-actin domains responsible for these activities are not well characterized. We successfully separated through series genetic deletion/insertions in SipC. found that C terminus (amino acids 200–409) bundled...

10.1074/jbc.m109.094045 article EN cc-by Journal of Biological Chemistry 2010-03-09

Vaccines pave the way out of SARS-CoV-2 pandemic. Besides mRNA and adenoviral vector vaccines, effective protein-based vaccines are needed for immunization against current emerging variants. We have developed a virus-like particle (VLP)-based vaccine using baculovirus-insect cell expression system, robust production platform known its scalability, low cost, safety. Baculoviruses were constructed encoding spike proteins: full-length S, stabilized secreted or S1 domain. Since subunit S only...

10.1128/mbio.01813-21 article EN cc-by mBio 2021-10-12

Mitochondrial antiviral signaling protein (MAVS) is a crucial adaptor in the sensing of positive-sense RNA viruses and subsequent induction innate immune response. Coronaviruses have evolved multiple mechanisms to evade this response, amongst others, through their main protease (Mpro), which responsible for proteolytic cleavage largest part viral replicase polyproteins pp1a pp1ab. Additionally, it can cleave cellular substrates, such as factors, dampen Here, we show that MAVS cleaved cells...

10.3390/v16020256 article EN cc-by Viruses 2024-02-05

Abstract The spike protein (S) of SARS-CoV-2 induces neutralizing antibodies and is the key component current COVID-19 vaccines. most efficacious vaccines are genetically-encoded spikes with a double proline substitution in hinge region to stabilize S prefusion conformation (S-2P). A subunit vaccine can be valuable addition mRNA viral vector-based but requires high stability spike. In addition, further stabilization might improve immunogenicity. To test this, five proteins were designed...

10.1038/s41598-024-56293-x article EN cc-by Scientific Reports 2024-03-08

In order to detect and respond invading pathogens, mammals have evolved a battery of pattern recognition receptors. Among these, RIG-I-like receptors (RLR) are cytosolic RNA sensors that play an essential role in the innate immune response against viruses, including coronaviruses. return, coronaviruses acquired diverse strategies impair RLR-mediated responses enable productive infection. Viral evasion mechanisms been well studied for highly pathogenic human (HCoVs), often, these activities...

10.3390/ijms26031197 article EN International Journal of Molecular Sciences 2025-01-30

A Yersinia pestis-human protein interaction network is reported here to improve our understanding of its pathogenesis. Up 204 interactions between 66 Y. pestis bait proteins and 109 human were identified by yeast two-hybrid assay then combined with 23 previously published construct a protein-protein network. Topological analysis the revealed that targeted significantly enriched in are central Analysis this showed signaling pathways important for host immune responses preferentially pestis,...

10.1128/iai.05622-11 article EN Infection and Immunity 2011-09-13

Abstract Development of effective preventative interventions against SARS-CoV-2, the etiologic agent COVID-19 is urgently needed. The viral surface spike (S) protein SARS-CoV-2 a key target for prophylactic measures as it critical replication cycle and primary neutralizing antibodies. We evaluated design elements previously shown other coronavirus S protein-based vaccines to be successful, e.g. prefusion-stabilizing substitutions heterologous signal peptides, selection S-based vaccine...

10.1101/2020.07.30.227470 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-07-30

Virus-specific cellular and humoral responses are major determinants for protection from critical illness after SARS-CoV-2 infection. However, the magnitude of contribution each components to viral clearance remains unclear. Here, we studied timing in relation 122 immune parameters 102 hospitalised patients with moderate severe COVID-19 a longitudinal design. Delayed was associated more disease higher levels SARS-CoV-2-specific (neutralising) antibodies over time, increased numbers...

10.3390/cells11172743 article EN cc-by Cells 2022-09-02

The delivery of effector proteins by Salmonella across the host cell membrane requires a subset effectors secreted type III secretion system (TTSS) known as translocators. SipC and SipB are translocator that inserted into membranes presumably form channel translocates cell. molecular events how these translocators insert remain unknown. We have previously shown C-terminal amino acid region (321-409) is required for translocation cells. In this study, we demonstrate ability to SipC-SipB...

10.1371/journal.pone.0060499 article EN cc-by PLoS ONE 2013-03-27

Coronaviruses express a papain-like protease (PLpro) that is required for replicase polyprotein maturation and also serves as deubiquitinating enzyme (DUB). In this study, using Middle East respiratory syndrome virus (MERS-CoV) PLpro modified in which the DUB selectively inactivated, we show an important MERS-CoV interferon antagonist virulence factor. Although DUB-negative rMERS-CoVMA replicates robustly lungs of human dipeptidyl peptidase 4 knock-in (hDPP4 KI) mice, it does not cause...

10.1038/s41467-023-36754-z article EN cc-by Nature Communications 2023-02-28

ObjectivesThe aim of this study was to assess safety and immunogenicity a dose-sparing fractional intradermal (ID) booster strategy with the mRNA-1273 COVID-19 vaccine.MethodsCOVID-19 naive adults aged 18-30 years were recruited from previous on primary vaccination regimens that compared 20 μg ID vaccinations 100 IM as series. Participants previously immunized randomly assigned (1:1) receive dose (20 μg) or standard-of-care intramuscular (IM) (50 vaccine, six months after completing their...

10.1016/j.cmi.2024.03.028 article EN cc-by Clinical Microbiology and Infection 2024-03-01

Immunosuppressive agents are known to interfere with T and/or B lymphocytes, which required mount an adequate serologic response. Therefore, we aim investigate the antibody response SARS-CoV-2 in liver transplant (LT) recipients after COVID-19.Prospective multicentre case-control study, analysing antibodies against nucleocapsid protein, spike (S) protein of and their neutralising activity LT confirmed infection (COVID-19-LT) compared immunocompetent patients (COVID-19-immunocompetent)...

10.1136/gutjnl-2021-326609 article EN Gut 2022-01-05

Summary Actin nucleation is the rate‐limiting step in actin assembly and regulated by actin‐binding proteins signal transduction molecules. Salmonella enterica serovar Typhimurium exploits dynamics reorganizing host cytoskeleton to facilitate its own uptake. SipC a protein that nucleates filament formation vitro . The molecular mechanism which not known. We show here 199–409 forms multimers promote nucleation. found wild‐type dimers while #1, mutant, less efficient dimer multimer formation....

10.1111/j.1365-2958.2007.06024.x article EN Molecular Microbiology 2007-11-13

Article23 August 2021Open Access Source DataTransparent process A Brucella effector modulates the Arf6-Rab8a GTPase cascade to promote intravacuolar replication Elizabeth Borghesan Paul G. Allen School for Global Health, Washington State University, Pullman, WA, USA These authors contributed equally this work. Search more papers by author Erin P Smith orcid.org/0000-0003-4822-476X Sebenzile Myeni Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Institutes...

10.15252/embj.2021107664 article EN cc-by The EMBO Journal 2021-08-23

SARS-CoV-2 is the third zoonotic coronavirus to cause a major outbreak in humans recent years, and many more SARS-like coronaviruses with pandemic potential are circulating several animal species. Vaccines inducing T cell immunity against broadly conserved viral antigens may protect hospitalization death caused by outbreaks of such viruses. We report design preclinical testing 2 cell-based pan-sarbecovirus vaccines, based on regions within proteins sarbecovirus isolates human other carrier...

10.1172/jci.insight.172488 article EN cc-by JCI Insight 2023-09-14

Abstract Safe and effective coronavirus disease (COVID)-19 vaccines are urgently needed to control the ongoing pandemic. While single-dose vaccine regimens would provide multiple advantages, two doses may improve magnitude durability of immunity protective efficacy. We assessed one- two-dose Ad26.COV2.S candidate in adult aged non-human primates (NHP). A regimen induced higher peak binding neutralizing antibody responses compared a single dose. In one-dose were stable for at least 14 weeks,...

10.1101/2020.11.17.368258 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-11-17

Brucella abortus, the intracellular causative agent of brucellosis, relies on type IV secretion system (T4SS) effector-mediated modulation host cell functions to establish a replicative niche, Brucella-containing vacuole (BCV). exploits host's endocytic, secretory, and autophagic pathways modulate nature function its from an endocytic BCV (eBCV) endoplasmic reticulum (ER)-derived (rBCV) egress (aBCV). A role for ER-associated degradation pathway (ERAD) in B. abortus cycle was recently...

10.1128/iai.00130-23 article EN Infection and Immunity 2023-04-27
Coming Soon ...